Regeneron CEO 23andMe Bid - Search News

News

23andMe, Regeneron and Anne Wojcicki

CNBC on MSN · 2d

Former 23andMe CEO Anne Wojcicki wins bid for control of her former company, topping Regeneron

Anne Wojcicki, former chief executive of 23andMe, won a bid to acquire the genetic testing company she founded in a second auction.

Regeneron Backs Off 23andMe, Losing Bid to Former CEO

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” according to a spokesperson for the pharma.

Seeking Alpha on MSN · 1d

Regeneron is said to have declined a higher bid for 23andMe after Wojcicki's offer

Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a non-profit led by the company’s co-founder and former CEO Anne Wojcicki proposed a better offer to acquire the bankrupt DNA testing company.

12don MSN

Fate of 23andMe genetic data still not settled amid bankruptcy fight

Me is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, ...

13don MSN

23andMe’s DNA Data Soars in Value With New $305 Million Bid

Bankrupt genetic analysis company 23andMe will hold a second auction for its cache of DNA data with an opening bid of $305 ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results